<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02461082</url>
  </required_header>
  <id_info>
    <org_study_id>PD-EMST-TMS</org_study_id>
    <nct_id>NCT02461082</nct_id>
  </id_info>
  <brief_title>EMST and TMS for Treatment of Dysphagia in Parkinson's Disease</brief_title>
  <official_title>Expiratory Muscle Strength Training (EMST) and Transcranial Magnetic Stimulation (TMS) for Treatment of Swallowing Disorders in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsche Parkinson Vereinigung e.V. (dPV)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine the effectiveness of different methods for the
      treatment of dysphagia in Parkinson's disease (PD). More than 80% of patients suffering from
      PD develop dysphagia during the course of their disease leading to malnutrition, loss of life
      quality, weight loss and pneumonia, which is the leading cause of death in these patients. So
      far, only a few specific treatment approaches have been investigated in PD patients with
      swallowing disorders. The investigator want to compare a 4-week expiratory muscle strength
      training (EMST), transcranial magnetic stimulation (TMS), and combination of both with a sham
      therapy. Dysphagia severity before and after intervention is measured by flexible endoscopic
      evaluation of swallowing (FEES). For the evaluation of changes in cortical swallowing
      processing the investigators apply magnetoencephalography (MEG).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dysphagia severity as measured by FEES</measure>
    <time_frame>Four weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortical reorganization of swallowing process as detected by MEG</measure>
    <time_frame>Four weeks and three month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life as measured by the swallowing quality of life questionnaire (Swal-Qol)</measure>
    <time_frame>Four weeks and three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphagia severity as measured by FEES</measure>
    <time_frame>Three month</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>EMST and sham-TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active expiratory muscle strength training in combination with sham transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-EMST and TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Sham expiratory muscle strength training in combination with active transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMST and TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active expiratory muscle strength training in combination with active transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-EMST and sham-TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Sham expiratory muscle strength training in combination with sham transcranial magnetic stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Expiratory muscle strength training (EMST)</intervention_name>
    <description>The EMST is performed 4 weeks, 5 days per week, for 20 minutes per day, using a calibrated or sham, handheld device (EMST 150, Aspire Products, Gainesville, FL).</description>
    <arm_group_label>EMST and sham-TMS</arm_group_label>
    <arm_group_label>sham-EMST and TMS</arm_group_label>
    <arm_group_label>EMST and TMS</arm_group_label>
    <arm_group_label>sham-EMST and sham-TMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial magnetic stimulation (TMS)</intervention_name>
    <description>A sham or active transcranial magnetic stimulation is performed at the last 5 days of EMST training.</description>
    <arm_group_label>EMST and sham-TMS</arm_group_label>
    <arm_group_label>sham-EMST and TMS</arm_group_label>
    <arm_group_label>EMST and TMS</arm_group_label>
    <arm_group_label>sham-EMST and sham-TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hoehn &amp; Yahr stages II-IV

          -  Parkinson-related dysphagia

          -  Oral nutrition

          -  Ambulant setting

          -  No change of medication for at least 4 weeks before study inclusion

        Exclusion Criteria:

          -  Other causes for dysphagia

          -  Other neurological disease potentially causing dysphagia

          -  Dementia (MMSE&lt;25; Montreal cognitive assessment (MoCA)&lt;26)

          -  Severe depression (BDI&gt;19)

          -  Percutaneous endoscopic gastrostomy (PEG)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Warnecke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Muenster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias Warnecke, MD</last_name>
    <email>tobias.warnecke@ukmuenster.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inga Claus, MD</last_name>
    <email>inga.claus@ukmuenster.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of neurology, University Hospital of Muenster</name>
      <address>
        <city>Muenster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Warnecke, MD</last_name>
      <phone>0049-251-8348016</phone>
      <email>Tobias.Warnecke@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Warnecke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inga Claus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2015</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

